- Home
- EXTR vs ELVN Comparison
EXTR vs ELVN Comparison
Compare EXTR & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXTR | ELVN |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.2B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EXTR | ELVN |
|---|---|---|
| Price | $22.04 | $59.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $21.20 | ★ $43.40 |
| AVG Volume (30 Days) | ★ 1.7M | 829.1K |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 616.67 | 3.17 |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $1,283,593,000.00 | N/A |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $7.97 | N/A |
| P/E Ratio | $71.00 | ★ N/A |
| Revenue Growth | ★ 12.59 | N/A |
| 52 Week Low | $13.48 | $14.79 |
| 52 Week High | $33.73 | $62.32 |
Technical Indicators
Market Signals| Indicator | EXTR | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 57.65 |
| Support Level | $16.48 | $56.69 |
| Resistance Level | $25.20 | $62.16 |
| Average True Range (ATR) | 0.71 | 2.05 |
| MACD | 0.09 | -0.47 |
| Stochastic Oscillator | 7.85 | 57.41 |
Price Performance
Historical ComparisonAbout EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.